Monitoring

Pro-active ongoing research to remain ahead of catalyst events and competitor activity

During monitoring engagements, we provide you with continuous and detailed insight into competitor activity and on your competitive environment. We use primary research, competitive intelligence and contextual analysis to inform your on-going strategic direction and activities, mapping key competitor presence and validating their strategies, actions and timelines as well as their product positioning and stakeholder outreach activities.

We relay these insights in the context of your market, therapeutic and treatment settings. Our consultants are highly experienced therapeutic area experts, adept in primary research and at shaping learnings into impactful analysis. We do not just report the facts but cut straight to the ‘so what’, elevating the implication and impact, based on our commercial and consulting experience.

In addition to providing a detailed understanding of the competitor landscape, competitor intent, capabilities and commercialisation activities, monitoring projects also provide tracking and impact reporting of catalyst and unscheduled market events.

Over the course of a Monitoring project, we will utilise a range of methodologies, including:

  • Secondary monitoring and on-going tracking of competitive commercial and clinical activity, regulatory, and key event catalysts
  • Primary research by engaging with industry stakeholders including ‘hidden from view’ company sources to discover competitive insight including commercialisation strategies
  • Alerts and email notifications of key events and implications to your team
  • Conference coverage in monitoring projects typically include between two to four conferences, where we conduct deep primary research with targeted stakeholders, including key opinion leaders, company sources and attending prescribers.

Learn more about our conference coverage

  • Frequently, clients add on strategic workshops, scenario or competitor simulation events throughout the year, to support brand planning and to optimise development strategies.

Learn more about our workshops

16

the average number of companies included in a monitoring project

>250

company sources interviewed over a 12 month period

70%

share of US, EU and Japan in geographical scope

Recent projects

Here are some examples of recent projects we have worked on:

Case Study One

The Brief

Support the launch strategy for a new oncology product

The Project

We conducted a 12-month monitoring project on three key competitors and several minor ones providing the client with daily alerts and monthly reports based on primary and secondary insights.

We provided an analysis of the potential impact to the client, along with coverage of three conferences.

Original scope was extended to assess TA developments across broader geographies.

The Discovery

We provided the client team with valuable insights into competitor strategy and timelines as they prepared to launch in US and EU.

Our insights helped to inform the long-term strategy for their flagship asset in both the mono and combo space.

Case study two

The Brief

Enable the brand team to anticipate future entrants and prepare to launch a new treatment for a rare disease

The Project

We conducted a 12-month monitoring project of two rare indications in the US and EU with daily alerts and monthly reports.

In addition to monitoring we conducted ad hoc targeted primary research in response to competitor catalyst events adding depth of knowledge and understanding.

The Discovery

Initial baseline report outlining the current and future competitive landscape was updated on a monthly basis to reflect changing events. Insights helped to inform the client’s four-year forecast and strategy ahead of their AGM.

Case Study Three

The Brief

Support the brand team as they prepare for the launch of new in-class competitors and enter a new therapeutic space with an established product

The Project

We conducted a 12-month monitoring project of the full competitive landscape (> 70 assets) in two therapeutic indications, with a focus on four key competitors across three major markets; US, EU and Japan.

Client key deliverables included news alerts, quarterly reports and coverage of two major conferences in the US and the EU.

The Discovery

The monitoring project provided the client team with invaluable insights in understanding competitor launch strategy and messaging.

Insights enabled the team to refine their activities and messaging platform, to leverage incoming competition.

Our client extended the monitoring project for the third year to an additional therapeutic indication to support its LCM efforts.